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ligodendrocytes are critical for the development of
the plasma membrane and cytoskeleton of the axon.
In this paper, we show that fast axonal transport is
also dependent on the oligodendrocyte. Using a mouse
model of hereditary spastic paraplegia type 2 due to a null
mutation of the myelin 
 
Plp
 
 gene, we find a progressive
impairment in fast retrograde and anterograde transport.
Increased levels of retrograde motor protein subunits are
O
 
associated with accumulation of membranous organelles
distal to nodal complexes. Using cell transplantation, we
show categorically that the axonal phenotype is related to
the presence of the overlying 
 
Plp
 
 null myelin. Our data
demonstrate a novel role for oligodendrocytes in the local
regulation of axonal function and have implications for
the axonal loss associated with secondary progressive mul-
tiple sclerosis.
 
Introduction
 
The hereditary spastic paraplegias (HSPs) are a diverse
group of clinical syndromes in which the spastic paraparesis/
paraplegia may be the sole or predominant sign (pure
forms) or may coexist with other neurological deficits (com-
plicated forms). The essential pathology of HSP is degener-
ation of the distal regions of the corticospinal tracts with
preservation of their cell bodies. The disorders map to at
least 18 loci and may be inherited as autosomal-dominant
or -recessive or X-linked traits (for reviews see Crosby and
Proukakis, 2002; Fink, 2002; Reid, 2003). In the minority
of loci where a causal gene has been identified there is no
obvious commonality, with the products showing structural
and functional diversity often targeted to different locations
in the cell and expressed in various cell types. Many of the
candidate genes are expressed ubiquitously and show no
preferential expression for the subset(s) of neurons affected
in HSP. The pathogenesis of these disorders remains obscure,
although a failure in axonal transport has been proposed as
a common mechanism (Crosby and Proukakis, 2002) and
 
KIF5A
 
, encoding a neuronal-specific kinesin, has been
identified as the causal gene for spastic paraplegia type 10
(Reid et al., 2002).
X-linked spastic paraplegia type 2 is caused by mutations
of the proteolipid protein 1 (
 
PLP1
 
) gene, which encodes
PLP and its minor DM20 isoform, the major proteins of the
myelin sheath. One intriguing question is why mutations of
a gene expressed in oligodendrocytes leads to degeneration
of axons. Complete absence of PLP/DM20 due to gene dele-
tion or null mutation is associated with spastic paraplegia
type 2 and mild forms of Pelizaeus-Merzbacher disease. In
 
Plp
 
 null mice, the majority of axons are surrounded by an
appropriate thickness of myelin, which shows variable defects
of the intraperiod line but otherwise remains intact through-
out life (Klugmann et al., 1997). Axonal swellings (spheroids)
resulting from accumulations of membranous organelles
arise in small-diameter axons; such spheroids are often asso-
ciated with paranodal areas (Griffiths et al., 1998). Older
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mice develop an age- and length-dependent degeneration of
long spinal tracts, such as the fasciculus gracilis (Garbern et
al., 2002). Human patients lacking PLP/DM20 due to a
null mutation also show extensive axonal degeneration in
the distal corticospinal tracts and fasciculus gracilis and a
more diffuse axonal loss throughout much of the cerebral
white matter; surviving axons are surrounded by myelin
sheaths (Garbern et al., 2002). Therefore, absence of the
myelin protein PLP/DM20 results in diffuse axonal swell-
ings and selective axonal degeneration of specific long spinal
tracts in both man and mouse.
In this paper, we test and verify the hypothesis that ab-
sence of PLP/DM20 in oligodendrocytes impairs fast axonal
transport. This provides the first direct functional demon-
stration of a pathogenetic mechanism for any of the HSP
disorders, and offers a further insight into how oligodendro-
cytes influence the function of axons.
 
Results
 
Membranous organelles accumulate preferentially 
at the distal juxtaparanode
 
To ascertain the evolution of axonal changes, we examined
the optic nerves of 
 
Plp
 
 null mice at P20, 40, 60, and 120.
No definitive changes were recognized at P20, but by P40
focal accumulations of membranous organelles, principally
dense bodies and mitochondria, were present. These in-
creased in frequency and extent by P120. Consistent with
Figure 1. Membranous organelles 
accumulate preferentially distal to the 
nodal complex in optic nerve axons of 
PLP/DM20-deficient mice. (A) Schematic 
showing the axon and surrounding myelin 
sheath. The length of axon myelinated 
by a single oligodendrocyte process is 
termed the internode and terminates at 
the nodes of Ranvier (N). (B) The boxed 
area from A is shown in detail. The node 
of Ranvier is abutted by the paranode, 
the region at which the terminal loops
of individual myelin lamellae (arrow 1) 
appose the axolemma in an orderly 
manner. The juxtaparanode (JPN) is the 
region between the paranode and the 
internode. The paranodal axo–glial 
junction (arrow 2) is a highly specialized 
intercellular junction (shown in more 
detail in Fig. S1 D, available at http://
www.jcb.org/cgi/content/full/
jcb.200312012/DC1). (C) Wild-type 
axon showing a nodal complex. The 
node (N), paranode (P), and juxta-
paranodal (J) regions are indicated, as 
is the distal (chiasmal) side. In this par-
ticular example only one axonal mito-
chondrion is evident (arrow), although 
in other instances several organelles may 
be present. Bar, 2 m. (D) In this and 
subsequent images the axons are from 
Plp null mice. A small accumulation of 
dense bodies and mitochondria (arrow) 
are present at the distal juxtaparanode 
(J). The proximal juxtaparanode and 
internode contain several nonclustered 
mitochondria, which is slightly in excess 
of the maximum number observed in 
wild-type axons. However, there is a 
distinct difference between proximal 
and distal regions. Bar, 2 m. (E) In this 
example the accumulated dense bodies 
and mitochondria occupy the distal 
internode, juxtaparanode (J), and para-
node (Pd), and have also extended into 
the nodal (N) region; the proximal para-
node (Pp) remains unaffected. Bar, 2 m. 
(F) A proportion of optic nerve axons in Plp null mice have nonmyelinated regions interposed between myelinated internodes. In this example 
the proximal axon (Ax) is unmyelinated, whereas the distal axon is myelinated. A heminode with its paranode (P) is present. A collection of 
organelles, predominantly dense bodies (arrow), is present distal to the paranode, whereas no accumulation is present proximally. Bar, 2 m. 
(G) The distal aspect of a nodal complex is shown with the paranode (P) marked. The distal axon contains a small accumulation of mitochondria. 
Bar, 1 m. (H) Another axon shows accumulation of dense bodies distal to the paranode (P). Bar, 1 m.
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our earlier report (Griffiths et al., 1998), we noted a ten-
dency for organelles to accumulate distal to a nodal com-
plex, often commencing in the region of the juxtaparanode
(see Fig. 1, A and B for terminology) and then extending.
The axon proximal to the node was either normal or was af-
fected to a much lesser degree (Fig. 1, D–F). Quantifica-
tion at P40 showed that the frequency of accumulations
was much greater on the distal (51.3 
 

 
 4.9%) compared
with the proximal (12.1 
 

 
 5%; P 
 

 
 0.001) side of the
node. Changes in the null mice were also significantly dif-
ferent from the wild type, in which organelle accumulation
was noted at 3.7 
 

 
 1% of distal and 0% of proximal nodal
regions. At P40 the 
 
Plp
 
 null axons were seldom swollen,
but by P60 and subsequently focal swellings and associated
attenuation of the overlying sheath were evident in some
fibers (Fig. S1, A–C; available at http://www.jcb.org/cgi/
content/full/jcb.200312012/DC1). The swellings were pre-
sent along the length of the optic nerve, the tract, and in
the brachium of the superior colliculus (unpublished data).
The axonal cytoskeletal organization was disrupted within
and immediately adjacent to the area of the accumulations/
swellings. Neurofilaments (NFs) and microtubules were ei-
ther displaced to a small domain of the axon or replaced by
a fine granular amorphous material (Fig. 1, G and H). Out-
side of the focal accumulations of organelles, the organiza-
tion of the axonal cytoskeleton appeared normal. The para-
nodal axo–glial junction was intact with regular arrays of
transverse bands on the external axolemma (Fig. S1 D).
Occasional myelinated fibers undergoing Wallerian degen-
eration were noted in the optic nerve at P120.
 
Accumulation of axonal organelles relates to 
PLP-deficient myelin
 
Due to random X-inactivation, 
 
Plp
 

 
/
 

 
 heterozygotes are chi-
meras in which internodes may be formed from PLP/
DM20
 

 
 or PLP/DM20-deficient myelin (Yool et al., 2001).
Using the optic nerve, we determined whether the accumu-
lations of membranous organelles were biased toward one
population of internodes. At P40, all accumulations of or-
ganelles (
 
n
 
 mice 
 

 
 3; 
 
n
 
 spheroids examined 
 

 
 67) were as-
sociated with PLP/DM20-deficient myelin, and even at one
year of age 95 
 

 
 3% (
 
n
 
 mice 
 

 
 3; 
 
n
 
 spheroids 
 

 
 48) re-
mained associated with such internodes. These findings sug-
gest that once formed, the spheroids show little tendency to
migrate along the axon.
 
Differentiation of the axonal cytoskeleton and 
axolemma occurs in the absence of PLP/DM20
 
Regional differentiation of the axolemma, phosphorylation
of the axonal cytoskeleton, and ultimately axonal size (Brady
et al., 1999; Gotow et al., 1999; Sánchez et al., 2000; Kirk-
patrick et al., 2001) depend on contact with myelin-forming
oligodendrocytes. Axonal diameter frequency distributions
and axonal density in the optic nerve (Fig. 2 A) and ventral
spinal cord of wild-type and 
 
Plp
 
 null mice at P20 and P60
were similar. No difference was detected in the NF popula-
tions of the optic nerve and spinal cord of 
 
Plp
 
 null mice at
P20 and P60 by Western blotting (Fig. 2, B and C) or im-
munostaining (unpublished data). Caspr-1 and Kv1.1, mo-
lecular markers of the paranode and juxtaparanode, respec-
tively (Peles and Salzer, 2000), were present in 
 
Plp
 
 null mice
Figure 2. Absence of PLP/DM20 in 
oligodendrocytes does not impair the 
differentiation of axonal cytoskeleton 
and axolemma. (A) Axonal diameter 
frequency distributions from optic nerves 
of P60 wild-type and Plp null mice; the 
profiles are identical. (M  SEM; n  4). 
Inset: axonal densities in the optic nerve 
are also unaltered in the Plp null mice at 
P60. (M  SEM; n  4). (B) Levels of NF 
proteins in the triton-insoluble fraction 
from optic nerves of P60 Plp null mice 
are not different from wild-type littermates. 
(M  SEM; n  4 or 5). Similar results 
were found using the cytoskeletal-
enriched fraction from brain and spinal 
cord (C). Representative immunoblots: 
NF-L recognizes the light chain NF, SMI-
31 recognizes phosphorylated epitopes 
on the NF-H (h) and NF-M (m) polypep-
tides; RT-97 recognizes a different phos-
phorylated epitope on NF-H, and SMI-
32 detects nonphosphorylated epitopes 
on NF-H. (D) Molecular markers for the 
node, ankyrin (red) and axolemma of 
the paranode, caspr-1 (green), and juxta-
paranode, Kv1.1 (green) in P60 optic 
nerves from wild-type (WT) and Plp null 
(KO) mice. The localization appears sim-
ilar in both genotypes. The Kv1.1 staining 
of the juxtaparanode is separated from 
the node by a gap, which represents the 
paranodal region. Bar, 5 m.
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(Fig. 2 D) as were the paranodal transverse bands (Fig. S1
D). Neurofascin, which marks the oligodendrocyte paranodal
loops, was also present (unpublished data).
 
Absence of PLP/DM20 in the oligodendrocyte induces 
a local axonopathy
 
To demonstrate unequivocally that the axonopathy resulted
only from absence of PLP/DM20 in the overlying oligoden-
drocyte, we transplanted neurospheres from 
 
Plp
 
 null or wild-
type mice into the dorsal columns of the myelin-deficient
 
shiverer
 
 mutant. The transplanted myelin basic protein
(MBP
 

 
) myelin was clearly distinguishable against the nega-
tive background of the 
 
shiverer
 
 host (Fig. 3, A–C). None of
the mice (0/7) myelinated by transplanted wild-type cells de-
veloped any axonal abnormalities (Fig. 3 D; Fig. S2 A, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200312012/
DC1), whereas all (4/4) of the grafts myelinated by 
 
Plp
 
 null
cells contained axonal changes characterized by accumulation
of membranous organelles, sometimes adjacent to paranodes
(Fig. 3 F). The myelin sheaths generated by the 
 
Plp
 
 null cells
(Fig. 3 G) showed the characteristic changes described previ-
ously (Boison et al., 1995; Yool et al., 2002a) in comparison
with the wild-type myelin (Fig. 3 E). By EM, 1–3 abnormal
axons were detected per grid square (9,409 
 

 
2
 
) of the PLP-
deficient transplants (Fig. S2, B–D). No alterations were
noted in 
 
shiverer
 
 axons outside the grafted region.
 
Absence of PLP impairs fast axonal transport systems
 
The accumulation of axonal membranous organelles distal
to the node in the optic nerves of PLP/DM20-deficient mice
resembles the situation described distal to a cold block in the
sciatic nerve (Tsukita and Ishikawa, 1980), suggesting de-
fects in retrograde axonal transport. We examined this pa-
rameter more directly by injecting FITC-conjugated cholera
toxin B (CTB) into the superior colliculus and measuring its
accumulation in retinal ganglion cells (RGCs) 12 h after in-
jection at 1, 2, 4, 12, and 18 mo of age (Fig. 4 A). Signifi-
cantly less tracer was evident in the retina in 
 
Plp
 
 null mice
from 2 mo onward, the deficit worsening with age (Fig. 4, B
and C). The number of optic nerve axons (Fig. 2 A) and the
size of the RGCs (Fig. 4 D) were not significantly different
at P60, indicating these factors did not account for the re-
duction in the measured fluorescent signal. When a labeling
time of 6 h was used in 4-mo-old mice, fewer, less intensely
stained RGCs were detected in the null; the signal being
63% of wild type. No RGC labeling was seen in either geno-
type 3 h after injection. When the labeling interval was ex-
tended to 3 d the level of signal increased considerably in
wild type, but remained the same as for 12 h in the null mice
so that fluorescence was now only 31% of control. Focal ac-
cumulations of fluorescent tracer were found along the en-
tire length of the optic nerve in the 
 
Plp
 
 null mice, but oc-
curred only rarely in the wild type (Fig. 4, E–G).
We used a similar strategy to examine the accumulation of
anterogradely transported proteins 12 h after intraocular in-
jection of [
 
35
 
S]methionine. At 2 mo, there was no difference
in the accumulation of radiolabeled proteins in the superior
colliculus of 
 
Plp
 
 null compared with the wild-type mice. By 4
mo, a 25% reduction was evident, which increased to 54%
by 18 mo (Fig. 4 H). Immunostaining for 
 

 
APP is often used
to demonstrate defects in axonal transport. Immunostaining
of brain and optic nerve for 
 

 
APP and ubiquitin revealed
small focal swellings in white matter from 
 

 
2 mo of age (un-
published data). The frequency of the 
 

 
APP
 

 
 swellings did
not appear to increase between 3 mo and 1 year.
 
Levels of retrograde motor and associated proteins are 
elevated in the absence of PLP
 
To further evaluate the defects in axonal transport, we quan-
tified the levels of dynein intermediate chain and dynactin
p50, together with the heavy chain subunits of kinesin, in
triton-soluble extracts of optic nerves from 
 
Plp
 
 null mice and
Figure 3. PLP/DM20-deficient oligo-
dendrocytes induce a focal axonopathy 
when transplanted into the dorsal 
columns of shiverer mice. (A and B) 
Adjacent longitudinal resin sections of 
shiverer spinal cord transplanted with 
Plp null cells and immunostained for 
MBP (A) and PLP (B). The majority of 
myelin is in the dorsal columns. The 
transplanted myelin stains strongly for 
MBP (A), but is negative for PLP (B). 
Bar, 1 mm. When using this method of 
processing on resin sections, only the 
compact myelin of the transplant is 
immunostained. (C) shiverer axons are 
ensheathed, rather than myelinated, by 
oligodendrocyte processes that are PLP/
MBP, and a cryosection immuno-
stained for PLP (green) and MBP (red) 
shows two fibers at the junction between 
the host shiverer processes (shi) and the 
PLP/MBP myelin produced by the 
transplanted Plp null cells (null). Bar, 20 m. (D) Myelination by transplanted wild-type cells showing a node (N) and normal axonal appearance. 
Bar, 2 m. (E) Part of the wild-type myelin sheath with major dense (M, arrow) and intraperiod (I, arrow) lines. Bar, 50 nm. (F) Myelination by 
transplanted Plp null cells showing an axon containing numerous membranous organelles adjacent to a paranode (P). Bar, 2 m. (G) Part of 
the PLP-deficient myelin sheath showing widening of the intraperiod line. Bar, 50 nm.
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wild-type littermates at P20 (unpublished data) and P60
(Fig. 5, A and B). Using the preparative technique (see Ma-
terials and methods), this fraction will contain detergent-
extracted membrane proteins. The selected ages represent
times just before and after definitive ultrastructural evidence
of an axonopathy, respectively. Levels of dynein and dynac-
tin were significantly increased at both ages, more markedly
at P60, whereas kinesin levels were unchanged. As Lis1 and
Nudel also interact with and regulate dynein function, we
quantified their levels in the optic nerve at P60 and found
significant increases (Fig. 5, A and B). Similar results were
found for the spinal cord (Fig. 5, C and D), whereas no dif-
ference between wild type and null was detected in the cere-
bral cortex (Fig. 5, E and F). mRNA levels for cytoplasmic
dynein, as determined by RT-PCR, were not elevated in the
retinae of 
 
Plp
 
 null mice (Fig. 5 G) at P60.
To show that the elevated levels of the retrograde motor
proteins are related to the absence of PLP/DM20, we rescued
the null phenotype by complementation with a wild-type 
 
Plp
 
genomic transgene (Readhead et al., 1994; Griffiths et al.,
1998). Levels of dynein and dynactin in the 
 
Plp
 
 null and wild-
type mice expressing the transgene were the same as wild-type
mice, whereas in the absence of the transgene the 
 
Plp
 
 null
mice showed the expected elevations (unpublished data).
Although dynein and dynactin act to move cargoes in a
retrograde direction, they themselves must first be trans-
ported anterogradely to the nerve terminal. Approximately
75% of anterograde movement is in the in the slow compo-
Figure 4. Absence of PLP/DM20 is 
associated with impaired fast retrograde 
and anterograde axonal transport. 
(A) Schematic of the optic pathways 
showing the eye, optic nerve (ON), 
chiasm (C), optic tract (OT), and superior 
colliculus (SC). The distal optic tract 
continues as the brachium of the superior 
colliculus (not depicted) to terminate in 
the optic nerve layer of the colliculus. 
In rodents, 90% of axons in the optic 
nerve decussate at the chiasm and ter-
minate in the contralateral superior 
colliculus. The RGCs are the cell bodies 
of axons that terminate in the colliculus. 
(B) Area of retinal whole mount from 
wild-type (WT) and Plp null (null) litter-
mates aged 4 mo, 12 h after injection of 
FITC-conjugated CTB into the superior 
colliculus; images were collected and 
processed identically. The number of 
labeled RGCs and the intensity of fluores-
cence are much greater in the wild type. 
Bar, 50 m. (C) Accumulation of retro-
gradely transported CTB-FITC 12 h after 
injection into the superior colliculus in 
wild-type and Plp null littermates of 
denoted ages. The signal in the RGCs is 
expressed as fluorescence area (m2/
mm2) of retina. (M  SEM; n  4 or 5). 
The difference between the two geno-
types is significant at all ages except 1 
mo. (D) Frequency distribution of RGC 
body area as defined by immunostaining 
for -tubulin III in wild-type and Plp null 
littermates at P60. (M  SEM; n  2). 
There is no difference between the two 
genotypes. (E) Longitudinal sections of 
optic nerves from wild-type (WT) and Plp 
null mice at 4 mo of age, 48 h after injec-
tion of FITC-conjugated CTB into the 
superior colliculus. Only an occasional 
focus of fluorescent labeling is observed 
in the wild type, whereas numerous CTB-
filled axonal swellings are evident along the Plp null nerve. The direction of retrograde transport is indicated by the arrow. Bar, 200 m. 
(F) Enlargement of single swelling from E, showing a “tail” of tracer in the axon distal to the swelling. Bar, 10 m. (G) Section from the nerve 
shown in E, immunostained for caspr-1 (red) and NFs (blue). The FITC-conjugated CTB has accumulated distal to the nodal complex. The node 
(arrow) is bounded by the caspr-1–stained paranodes. The caspr-1 staining above and below the swelling belongs to other axons. Note the 
punctate staining of the CTB, suggesting its presence in membranous components such as endosomes. Bar, 5 m. (H) Accumulation of fast 
anterogradely transported protein in the superior colliculi of wild-type and Plp null mice at ages 2, 4, and 18 mo. The radiolabeled protein in 
the colliculi is expressed as a percentage of the total TCA-precipitated labeled material in the optic system. (M  SEM; n  5–7). The differences 
at 4 and 18 mo are significant.
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nent b compartment, with the remainder in the fast com-
ponent (Pfister, 1999; Susalka et al., 2000). To examine
whether the elevated levels of dynein and dynactin might
represent an effect on slow anterograde rather than retro-
grade movement, we measured levels of actin (Fig. 5 B) and
spectrin, two main components of the slow component b
compartments, in triton-soluble fractions of optic nerve.
The values for both proteins in the optic nerve were not dif-
ferent from wild type at P20 and P60.
Late onset distal axonopathy occurs in Plp knockout 
and heterozygous mice and is not prevented by the 
Wlds allele
Significant tract degeneration is associated with long spinal
pathways. At 8 mo of age, early degeneration was seen in
the fasciculus gracilis of the rostral cervical region, whereas
no degeneration was observed in the rostral thoracic fascicu-
lus gracilis until 18 mo (Garbern et al., 2002). Therefore,
we compared degeneration in the cervical fasciculus gracilis
between wild-type mice, Plp null mice, and Plp/ heterozy-
gotes at 18 mo. Wild-type mice showed no evidence of de-
generation (Fig. 6 A). The Plp null and heterozygous mice
contained obvious degenerating fibers (Fig. 6, B and C), and
although the frequency varied between different mice within
a genotype, there was minimal overall qualitative difference
between the amounts of degeneration in the two groups.
The Wlds locus on chromosome 4 retards Wallerian degen-
eration after axonal damage, resulting in prolonged survival
of the distal axon. By appropriate cross mating we generated
Plp null mice expressing the Wlds allele, and at 4 and 18 mo
of age determined if axonal changes were prevented or ame-
liorated. Axonal swellings in the optic nerve (unpublished
data) and degeneration in the fasciculus gracilis (Fig. 6 D)
were present and appeared identical in extent and distribu-
tion to those in the unmodified Plp null mice. We conclude
that, at the ages examined, expression of the Wlds allele does
not protect against the axonopathy induced by lack of PLP/
DM20, in contrast to the peripheral neuropathy associated
with P0 deficiency (Samsam et al., 2003).
Discussion
Impairment of axonal transport has emerged as a putative
common factor in the pathogenesis of HSP (Crosby and
Proukakis, 2002). Despite strong circumstantial evidence,
conclusive proof has been absent, although recently a late
impairment in transport has been verified in paraplegin-defi-
cient mice (Ferreirinha et al., 2004). In this paper, we show
that absence of the major myelin protein, PLP/DM20, from
the oligodendrocyte, causes an early impairment of transport
in the underlying axon, leading to multifocal accumulations
of membranous organelles. Although this effect appears gen-
eralized, at least in smaller-diameter myelinated fibers, de-
generation is concentrated at the distal regions of the longer
axons. Traditionally, the main function of myelin has been
viewed as the promotion of saltatory conduction. Increas-
ingly, it is recognized that this is but one of many roles, and
our analysis identifies a further function related to fast ax-
onal transport and, furthermore, links this to a specific my-
elin molecule.
The oligodendrocyte provides local support for the axon
Two key observations indicate that the axonal changes are
related to the absence of PLP/DM20 in the overlying my-
elin, and are not neuronally autonomous. Organelles accu-
mulate only beneath the PLP/DM20-deficient myelin in
Plp/ heterozygotes and are absent in nonmyelinated ax-
ons. However, the presence of axonal swellings and organelle
accumulations in the shiverer axons, only in association with
Figure 5. Absence of PLP/DM20 is associated with elevated levels 
of retrograde motor proteins in affected regions. (A–F) Steady-state 
levels of dynein intermediate chain, dynactin p50, kinesin heavy 
chain, Lis1, and Nudel in triton-extracted fractions of optic nerve 
(A and B), spinal cord (C and D), and cerebral cortex (E and F) of Plp 
null mice at P60. Bar charts (A, C, and E) show the percent change 
from wild-type littermates (M  SEM; n  3–7); panels (B, D, and F) 
show representative blots. The protein loading for dynein in the 
wild-type spinal cord is threefold greater than the null (3:1). In the 
optic nerve, all values except kinesin are significantly elevated in 
the Plp null mice. In the spinal cord dynein, dynactin and Lis1 are 
increased, whereas in the cerebral cortex there is no difference in 
any parameter (G). Representative RT-PCR of dynein intermediate 
chain genes 1 (Dnci1) and 2 (Dnci2) from retinae of P60 wild-type 
and Plp null mice. Two alternatively spliced Dnci1 transcripts (1a 
and 1c) are present. Cyclophilin (Cyclo) acts as an internal control. 
There is no difference in signals between the two genotypes.
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the transplanted mutant oligodendrocytes, provides conclu-
sive evidence that the PLP/DM20 deficiency is sufficient to
cause the transport changes in the underlying axon.
With the major biosynthetic pathways localized in the
neuronal soma, the axon is largely dependent on the cell
body for maintenance. However, the ability of oligodendro-
cytes to influence the differentiation and maintenance of the
axolemma is well recognized (Kordeli et al., 1990; Davis et
al., 1996; Einheber et al., 1997; Menegoz et al., 1997; Ras-
band et al., 1999), and their effect on the major cytoskeletal
elements has been linked to myelin status, being altered in
hypomyelinating mutants (Brady et al., 1999). The localiza-
tion of mitochondria within the axon has also been linked to
the presence of overlying myelin (Bristow et al., 2002). Our
data indicate novel, oligodendrocyte-dependent modulation
of fast axonal transport systems, operating locally at the level
of each myelinated internode. Furthermore, there is a strong
indication that this process is not dependent on the volume
of internodal myelin, per se, but on specific myelin mole-
cules. This view is strengthened by our recent observation
that absence of CNP, another myelin protein, results in a
virtually identical axonopathy in the presence of normal my-
elin (Lappe-Siefke et al., 2003). The results suggest that oli-
godendrocytes communicate in some way with the underly-
ing axon and support axonal function. A locally acting
mechanism is compatible with the localization of spheroids
to the PLP/DM20-deficient myelin in the Plp/ heterozy-
gotes and with the fact that few neuronal cell bodies degen-
erate in the Plp knockout mouse, the latter being a feature
common to HSPs. In our mice, axon densities in the optic
nerve and the size of the RGCs were identical between null
and wild-type mice at 2 mo (an age at which retrograde
transport was significantly impaired), and DiI labeling of
RGCs of old mice via the nerve (unpublished data) indi-
cated no apparent cell loss.
PLP/DM20 is necessary for fast transport
in myelinated axons
The absence of PLP/DM20 from the overlying oligodendro-
cyte perturbs anterograde and retrograde axonal transport,
although the organelle accumulation distal to nodes proba-
bly results from a defect in the latter. With regard to retro-
grade transport, the experiments using CTB-labeling periods
of 6, 12, and 72 h suggest that initially, a proportion of ax-
ons is capable of transporting a reduced amount of substrate
at a rate similar to the wild type; in other fibers transport is
delayed or ceases completely. The most probable explana-
tion is that retrograde transport is transiently delayed at af-
fected nodal regions, which occur along the whole length of
the visual pathway from the optic nerve to the colliculus.
Eventually, transport arrests or is severely retarded in an in-
dividual fiber, and the number of blocked axons increases
with age. In support of this, intensely fluorescent accumula-
tions of CTB, with an appearance suggesting endosomal lo-
Figure 6. Late-onset degeneration in the rostral 
cervical fasciculus gracilis of mice aged 18 mo. 
(A) Wild-type (WT) mouse. (B) Plp null (Plp/y) 
mouse showing axonal degeneration. (C) Plp 
heterozygous (Plp/) mouse showing a pattern of 
degeneration very similar to that occurring in the 
null mouse. (D) Plp null mouse carrying the Wlds 
mutation (Wlds) that retards Wallerian degeneration 
after axonal transection. The pattern of axonal 
degeneration is very similar to that in the unmodified 
Plp null mouse, indicating the Wlds mutation 
provides no obvious protection. Bar, 50 m. Insets: 
the fasciculus gracilis at higher power with the 
normal appearance in the wild-type mouse, and 
changes typical of axonal degeneration (arrow) 
in the other three genotypes. Bar, 10 m.
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calization, were seen in optic nerve sections of Plp null mice,
but rarely in wild-type mice. Interestingly, defects in endo-
somal function have been linked with other types of HSP or
motorneuron disease (X.P. Zhao et al., 2001; Patel et al.,
2002; Verhoeven et al., 2003; Yamanaka et al., 2003), sug-
gesting that retrograde transport and membrane recycling
processes are critical for neuronal survival. Although antero-
grade transport is impaired, we could detect no morphologi-
cal correlate, such as accumulation of vesicular or tubular
bodies at the proximal side of nodes. It may be that the
spheroids act as a barrier to anterograde movement.
Absence of PLP/DM20 is associated with changes
in levels of motor proteins
Kinesin and dynein are multi-subunit ATPases responsible
for transport of membranous organelles and proteins along
microtubules in the anterograde and retrograde directions,
respectively. Dynein is associated with various adaptor and
regulatory proteins including dynactin, Lis1, and Nudel.
The optic nerve and spinal cord represent regions of the cen-
tral nervous system that contain numerous axonal swellings;
conversely, few swellings are present in the cerebral cortex.
We find that steady-state levels of proteins in the dynein
complex are elevated in triton-soluble extracts of the optic
nerve and spinal cord of Plp null mice, whereas the cerebral
cortex is not different from wild type. Kinesin levels are also
unchanged at all locations. Therefore, the changes in retro-
grade motor proteins parallel the severity of the axonopathy.
As there is no evidence of increased transcriptional activity
in RGCs, the raised levels probably reflect the gradual accu-
mulation of retrogradely moving organelles with their at-
tached motor proteins. During the evolution of the axonop-
athy, one might envisage a retrogradely moving organelle
reaching a particular nodal complex where it either “derails”
from the microtubule or its further progress is blocked. We
cannot exclude that some of the membranous bodies at the
juxtaparanode are not transported from the axon terminal,
but arise locally by invagination of the axolemma (Novotny,
1984). Such invaginations, which entrap oligodendrocyte
membrane and cytoplasm, could also provide a potential
glia-to-axon signaling pathway.
The significance of the elevated motor protein levels still
has to be determined. However, mutations that disrupt ei-
ther the dynein complex or kinesin result in failure of axonal
transport, blockage of membranous cargoes, and axonal de-
generation in both Drosophila and mammals (Hurd and Sax-
ton, 1996; Martin et al., 1999; C. Zhao et al., 2001; La-
Monte et al., 2002; Hafezparast et al., 2003).
Axonal degeneration is dependent on length of fiber 
and duration of disease
Only a small minority of optic axons in Plp null mice and
humans ultimately degenerate despite the marked impair-
ment in retrograde transport. In contrast, the distal regions
of fibers in the cervical fasciculus gracilis and corticospinal
tracts degenerate progressively (Garbern et al., 2002), sug-
gesting that the length of the axon is critical in determining
whether or not it will undergo degeneration. Over time, the
extent of the degeneration tends to move proximally, toward
the cell body, in a manner typical of a distal (dying back) ax-
onopathy (Spencer and Schaumburg, 1976). Similar degen-
eration occurs in the fasciculus gracilis of Plp/ heterozy-
gotes in which 66% of internodes are myelinated by
PLP myelin (Yool et al., 2001). This indicates that, pro-
vided the axon is of sufficient overall length, only a minority
of its distance needs to be associated with PLP/DM20-defi-
cient myelin for distal degeneration to occur.
Is the late-onset distal degeneration related to transport
defects? The kinesin and dynein mutants show that defects
in anterograde or retrograde transport can precipitate ax-
onal degeneration. Although we have not directly examined
transport in the long spinal tracts, the morphological changes
and transplant experiments suggest that transport is affected
in a manner similar to the optic nerve. As axonal degenera-
tion occurs at a time when both retrograde and anterograde
transport are affected, it is not possible to state whether de-
fects in one or both components is a probable precipitating
factor. Alteration in axonal transport has been suggested as
a common mechanism in the HSPs (Crosby and Proukakis,
2002) and in various other neurodegenerative disorders
(Gunawardena et al., 2003; Hiruma et al., 2003; Szebenyi
et al., 2003), although different pathways may lead to its
compromise depending on the specific gene mutation. In
most conditions the candidate gene is expressed predomi-
nantly in the neuron. Our findings also have implications
for diseases considered as primary myelin disorders, such as
multiple sclerosis. Axonal loss during the secondary pro-
gressive phase of multiple sclerosis has been attributed to
loss of oligodendroglial/myelin support (Bjartmar et al.,
2003), and our data establish that loss of oligodendroglial-
specific molecules can indeed lead to functional impairment
and loss of axons. The next step is to identify how these
molecules influence axons and the downstream intra-axonal
pathways.
Materials and methods
Mice
Plp null and wild-type male mice at P20, P60, P120, and various older
ages up to 2 years were examined. These mice were on the C57BL/6 back-
ground, although the targeting event was performed on stem cells derived
from 129SV mice. Genotyping was performed as described previously
(Klugmann et al., 1997). Mice on the C57BL/6 background homozygous
for the Wlds mutation were obtained commercially (Harlan UK Ltd.) and
were crossed with the Plp knockout mice to obtain double mutants. For
some experiments, female mice heterozygous for the Plp null allele were
also used. shiverer mice on a C3H/101 background were used as trans-
plant recipients.
Transgenic complementation of Plp null mice was achieved by cross
mating female heterozygous Plp/ mice with males from line 66 on a
C57BL/6 background carrying a wild-type Plp genomic transgene (Read-
head et al., 1994). Male offspring with and without the transgene were
used.
Tissue collection and preparation
Mice for EM were perfused with glutaraldehyde/PFA and tissue from the
second segment of the cervical spinal cord (C2) and mid-optic nerve was
processed for resin embedding (Griffiths et al., 1981). Mice for immunocy-
tochemistry were treated in various ways. For cryostat sections, mice were
perfusion fixed with 4% PFA or Zamboni’s fixative and tissue was cryopro-
tected in 20% sucrose. Tissue from other mice was dissected unfixed. All
tissue was embedded in OCT compound (Sakura Fintek Europe) and snap
frozen in isopentane cooled by liquid nitrogen. Cryosections were cut at
15 m. For paraffin sections, mice were perfusion fixed in 4% PFA in
phosphate buffer.
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Collicular injections for retrograde transport
To study retrograde axonal transport, wild-type and Plp null male litter-
mates at ages between 1 and 18 mo were injected with 1 l of 1% fluores-
cein-conjugated CTB (Sigma-Aldrich) in sterile water with 2% DMSO. In-
jection was made into the right superior colliculus (Fig. 4 A) using
stereotactic coordinates (bregma 3.6 mm caudally, 0.6 mm laterally,
and 1.75 mm ventrally). After a defined interval, mice were perfused with
0.9% saline and the left retina was prepared as a whole mount (Hess, 1987)
and fixed in 4% PFA in phosphate buffer. Between 12 and 16 digital images
(IX70 microscope, Olympus; Color CoolView camera, Photonic Sciences)
of each CTB-labeled retina were acquired. 3–4 positions between limbus
and optic disc at 3–4 different locations around the retina were selected un-
der phase optics, and the corresponding fluorescent image was stored. The
total area occupied by fluorescent signal was determined within a defined
area using Image-Pro Plus 4 software (Media Cybernetics); data are ex-
pressed as area of fluorescence per mm2 of retina. The areas of RGC bodies
were determined in P60 wild-type and Plp null retinae after immunostain-
ing with the neuron-specific marker, -tubulin III.
Intraocular injections for anterograde transport
To study anterograde axonal transport, 1 l of [35S]cysteine/methionine
(Amersham Biosciences), specific activity 66 Ci/l in sterile distilled wa-
ter, was injected into the left eye of wild-type and Plp null male littermates
at ages between P60 and 18 mo. The animals were maintained in the light
for 12 h before the left retina and optic nerve and right optic tract, chiasm,
and superior colliculus (Fig. 4 A) were dissected separately and homoge-
nized in 10 mM Hepes with 1 mM EDTA and protease and phosphatase
inhibitors (as for Western blotting). The homogenates were TCA precipi-
tated, resuspended in 0.1 M Tris base to which a liquid scintillant (Ecoscint
A; National Diagnostics) was added, and counted in a liquid scintillation
counter (1900 Series; Packard). Collicular counts (disintegrations per min-
ute) were expressed as a percentage of the total counts in all fractions.
Axonal morphometry and quantification of 
juxtaparanodal change
Axon diameter, density, and myelination status were assessed from electron
micrographs (37,500) of randomly selected fields of mid-optic nerve from
20-, 60-, and 120-d-old wild-type and Plp null mice (Yool et al., 2002b).
The frequency of axonal change at proximal and distal juxtaparanodal re-
gions was assessed in longitudinal sections of optic nerve of three wild-type
and five Plp null mice aged P40 (distal juxtaparanode refers to the juxtapara-
node within a nodal–paranodal complex that is further from the neuronal
cell body). Sections of optic nerve including the region of the retina and lam-
ina cribrosa were examined in the electron microscope by an observer un-
aware of their genotype. Proximal and distal juxtaparanodal regions were
identified in relation to the retina assuming all fibers were orientated in a ret-
inal-to-chiasmal direction. The regions were qualitatively assigned as nor-
mal or abnormal in relation to the accumulation of membranous organelles.
Optic nerves from female Plp/ heterozygotes were used to assess
whether the accumulations of membranous organelles showed a prefer-
ence to develop in association with internodes formed by PLP/DM20-defi-
cient or wild-type myelin. Membranous accumulations were identified in
longitudinal sections of optic nerve from groups of three mice aged P40
and 1 year using EM and were scored according to the nature of the intra-
period line of the associated myelin sheath (Boison and Stoffel, 1994;
Rosenbluth et al., 1996; Klugmann et al., 1997).
Transplantation into the spinal cord of shiverer mice
Neurospheres (Zhang et al., 1998) from newborn (P1) wild-type or Plp null
mice were dissociated into a single cell suspension and resuspended at a
concentration of 50,000 cells/l in L1 solution (Invitrogen). A thoracolum-
bar laminectomy was performed on shiverer pups aged between P14 and
P21, and 2 l of the suspension of wild-type or Plp null cells was injected
into the dorsal columns of littermates using a glass microelectrode con-
nected to a CellTram Oil manual piston pump (Eppendorf). The injection
site was marked with sterile charcoal and the wound was sutured. After
4 mo, the mice were perfused with a PFA/glutaraldehyde mixture and
longitudinal sections of the transplant site were prepared for resin embed-
ding. 1-m sections were immunostained for MBP and PLP and thin sec-
tions were prepared for EM. Seven shiverer mice transplanted with wild-
type cells and four mice transplanted with Plp null cells established
successful myelinated grafts and were used for analysis.
RT-PCR
RT-PCR was performed on retinae of four wild-type and Plp null mice at
P60 for dynein intermediate chain gene 1 using published primers (Crack-
ower et al., 1999) and gene 2 using forward primer 5	-ATTCAAGCAGGT-
GCTAAGCTGTCA-3	 and reverse primer 5	-TATTGCTGCGGTTATC-
CCAAAGCA-3	 (for full details see supplemental information, available at
http://www.jcb.org/cgi/content/full/jcb.200312012/DC1).
Immunocytochemistry
Antibodies. PLP/DM20 was stained with a rabbit pAb to the common
COOH terminus (271–276; donated by N.P. Groome, Oxford Brookes
University, Oxford, UK), whereas PLP was stained with a pAb raised
against a PLP-specific peptide sequence (117–129; donated by Dr. E. Trief-
lieff, Chimie Organique des Substances Naturelles, Strasbourg, France). In
some experiments, PLP/DM20 was stained with a rat mAb against the
COOH terminus (ImmunoDiagnostics, Inc.). NFs were stained with SMI-
31 and SMI-32 (Sternberger Monoclonals, Inc.) recognizing phosphory-
lated and nonphosphorylated epitopes, respectively, of the NF-H and
NF-M polypeptides. The RT97 antibody (Wood and Anderton, 1981), which
recognizes a different phosphorylated epitope of the NF-H and NF-M pro-
teins (Sánchez et al., 2000), was also used (donated by J.N. Wood, Univer-
sity College Medical School London, London, UK). NF-M, NF-L, and
acetylated tubulin were stained with mAbs (Sigma-Aldrich). Caspr-1 was
stained with a rabbit pAb (Einheber et al., 1997; donated by E. Peles, The
Weizmann Institute of Science, Rehovot, Israel). Ankyrin G was stained
with a mouse mAb (Zymed Laboratories). Filamentous actin was recog-
nized by Bodipy-labeled phalloidin (Molecular Probes, Inc.). Neuronal
spectrin was stained with a rabbit pAb (CHEMICON International). Potas-
sium Kv1.1 channels and cytoplasmic dynein intermediate chain were
stained with a pAb and mAb, respectively (CHEMICON International).
Neurofascin was stained with an antibody provided by P.J. Brophy (Uni-
versity of Edinburgh, Edinburgh, UK; Tait et al., 2000). Dynactin p50 was
recognized with a mouse mAb (BD Biosciences), kinesin heavy chain (H2)
with a mouse mAb (CHEMICON International), -actin, -tubulin III, and
APP were recognized with mouse mAbs (Sigma-Aldrich), Lis1 with rabbit
and goat pAbs (donated by D. Smith [Harvard Medical School, Boston,
MA] and from Santa Cruz Biotechnology, Inc.), Nudel with a rabbit pAb
(donated by S. Hirotsune, Shirakawa Institute of Animal Genetics, Fuku-
shima, Japan), and ubiquitin with a rabbit pAb (DakoCytomation).
Immunostaining. For most antibodies, cryosections were fixed in 4%
PFA (for 20 min at 4
C), permeabilized in methanol (for 10 min at 20
C),
and primary antibodies, diluted in PBS/1% normal goat serum, were ap-
plied overnight (at 4
C) either as single or double stains. Secondary FITC or
Texas red–labeled conjugates diluted in the same buffer were applied for
30 min at RT. Staining for PLP/DM20 and the various NF antigens was also
performed on tissue perfused with PFA or Zamboni’s fixative. Sections
were then permeabilized by 0.5% Triton X-100/PBS for 30 min at RT, and
were blocked in 0.1% Triton X-100 and 0.2% pig skin gelatin in PBS. Pri-
mary and secondary antibodies were applied in the blocking buffer. When
labeling with phalloidin, the cryosections were permeabilized in acetone.
The various NF antibodies, APP, and ubiquitin were also used on paraffin
sections in conjunction with the PAP technique. Resin sections of the
transplanted spinal cords were immunostained for PLP and MBP using the
PAP technique.
Western blotting
Mice were killed by CO2 and brains (excluding the brain stem), spinal
cords, and optic nerves from wild-type and Plp null male littermates at P20
and P60 were rapidly removed, snap frozen in liquid nitrogen, and stored
at 80
C. Whole brain, cerebral cortices, and spinal cord were prepared
using a modification of the method of Gotow et al. (1999), and optic
nerves were divided into triton-soluble and -insoluble fractions (for details
of fractionation procedures see supplemental information, available at
http://www.jcb.org/cgi/content/full/jcb.200312012/DC1).
Protein concentrations were quantified using the BCA Protein Assay
System (Pierce Chemical Co.). Proteins were loaded on 7.5, 10, or 14%
acrylamide gels, subjected to SDS-PAGE, and transferred to Hybond™-P
membrane (Amersham Biosciences) using a semi-dry blotting system. Blots
were blocked in 5% skimmed milk in TBS (pH 7.4) and 0.1% Tween 20,
incubated with various primary antibodies in blocking solution, washed,
and then treated with HRP-labeled secondary antibodies (mouse HRP,
Sigma-Aldrich; rabbit HRP, Scottish Antibody Production Unit, Law Hospi-
tal, Carluke, Scotland) and visualized using the ECL system (Pierce Chemi-
cal Co.). Autoradiographs were scanned and quantified using Scion Image
for Windows (Scion Corporation).
Statistical analyses
The frequency of axonal changes in the proximal vs. distal juxtaparanode
of knockout and wild-type optic nerves was compared using the Fisher’s
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exact test. The frequency distribution of RGC area was compared with the
Chi-squared test. Levels of motor proteins in the central nervous system of
paired wild-type and null littermates were compared using a paired t test.
Other parameters between wild-type and knockout mice were compared
with a two-tailed Mann-Whitney test (significance was defined as 0.05)
(GraphPad Software).
Online supplemental material
Methods for RT-PCR and fractionation of tissue for Western blotting are
listed. Fig. S1 and Fig. S2 show EM of optic nerve and oligodendrocytes
transplanted to spinal cord, respectively. Online supplemental material
available at http://www.jcb.org/cgi/content/full/jcb.200312012/DC1.
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